nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—type 2 diabetes mellitus—coronary artery disease	0.447	1	CtDrD
Glipizide—PPARG—coronary artery disease	0.157	1	CbGaD
Glipizide—PPARG—Telmisartan—coronary artery disease	0.0863	0.353	CbGbCtD
Glipizide—CYP2C9—Fenofibrate—coronary artery disease	0.0144	0.0591	CbGbCtD
Glipizide—CYP2C9—Gemfibrozil—coronary artery disease	0.0115	0.0472	CbGbCtD
Glipizide—CYP2C9—Clopidogrel—coronary artery disease	0.01	0.0409	CbGbCtD
Glipizide—CYP3A4—Ticagrelor—coronary artery disease	0.00942	0.0385	CbGbCtD
Glipizide—CYP2C9—Pitavastatin—coronary artery disease	0.00875	0.0358	CbGbCtD
Glipizide—CYP2C9—Valsartan—coronary artery disease	0.00851	0.0348	CbGbCtD
Glipizide—CYP3A4—Fenofibrate—coronary artery disease	0.0084	0.0343	CbGbCtD
Glipizide—CYP3A4—Gemfibrozil—coronary artery disease	0.00671	0.0275	CbGbCtD
Glipizide—CYP2C9—Rosuvastatin—coronary artery disease	0.00645	0.0264	CbGbCtD
Glipizide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00629	0.0257	CbGbCtD
Glipizide—CYP2C9—Simvastatin—coronary artery disease	0.006	0.0245	CbGbCtD
Glipizide—CYP2C9—Lovastatin—coronary artery disease	0.00587	0.024	CbGbCtD
Glipizide—CYP2C9—Pravastatin—coronary artery disease	0.00587	0.024	CbGbCtD
Glipizide—CYP3A4—Clopidogrel—coronary artery disease	0.00582	0.0238	CbGbCtD
Glipizide—CYP3A4—Eplerenone—coronary artery disease	0.00541	0.0221	CbGbCtD
Glipizide—CYP2C9—Atorvastatin—coronary artery disease	0.00535	0.0219	CbGbCtD
Glipizide—CYP2C9—Losartan—coronary artery disease	0.00489	0.02	CbGbCtD
Glipizide—CYP3A4—Enalapril—coronary artery disease	0.00482	0.0197	CbGbCtD
Glipizide—CYP3A4—Ezetimibe—coronary artery disease	0.00375	0.0153	CbGbCtD
Glipizide—CYP3A4—Rosuvastatin—coronary artery disease	0.00375	0.0153	CbGbCtD
Glipizide—CYP2C9—cardial valve—coronary artery disease	0.00361	0.393	CbGeAlD
Glipizide—CYP3A4—Simvastatin—coronary artery disease	0.00349	0.0143	CbGbCtD
Glipizide—CYP3A4—Lovastatin—coronary artery disease	0.00341	0.014	CbGbCtD
Glipizide—CYP3A4—Pravastatin—coronary artery disease	0.00341	0.014	CbGbCtD
Glipizide—CYP3A4—Atorvastatin—coronary artery disease	0.00311	0.0127	CbGbCtD
Glipizide—CYP3A4—Losartan—coronary artery disease	0.00284	0.0116	CbGbCtD
Glipizide—Gliquidone—KCNJ8—coronary artery disease	0.000926	0.361	CrCbGaD
Glipizide—PPARG—artery—coronary artery disease	0.000925	0.101	CbGeAlD
Glipizide—PPARG—endothelium—coronary artery disease	0.000781	0.0851	CbGeAlD
Glipizide—Glisoxepide—KCNJ8—coronary artery disease	0.000669	0.261	CrCbGaD
Glipizide—PPARG—myocardium—coronary artery disease	0.000488	0.0532	CbGeAlD
Glipizide—KCNJ11—heart—coronary artery disease	0.000484	0.0528	CbGeAlD
Glipizide—KCNJ11—cardiovascular system—coronary artery disease	0.000457	0.0498	CbGeAlD
Glipizide—ABCC8—heart—coronary artery disease	0.000446	0.0486	CbGeAlD
Glipizide—ABCC8—cardiovascular system—coronary artery disease	0.000421	0.0459	CbGeAlD
Glipizide—PPARG—heart—coronary artery disease	0.000341	0.0371	CbGeAlD
Glipizide—PPARG—cardiovascular system—coronary artery disease	0.000321	0.035	CbGeAlD
Glipizide—PPARG—blood—coronary artery disease	0.000254	0.0277	CbGeAlD
Glipizide—Glyburide—CFTR—coronary artery disease	0.000231	0.0902	CrCbGaD
Glipizide—CYP2C9—heart—coronary artery disease	0.000199	0.0217	CbGeAlD
Glipizide—Glyburide—ABCA1—coronary artery disease	0.000197	0.0767	CrCbGaD
Glipizide—CYP2C9—cardiovascular system—coronary artery disease	0.000188	0.0205	CbGeAlD
Glipizide—Gliclazide—VEGFA—coronary artery disease	0.000187	0.073	CrCbGaD
Glipizide—CYP2C9—blood—coronary artery disease	0.000149	0.0162	CbGeAlD
Glipizide—CYP3A4—blood—coronary artery disease	0.000113	0.0124	CbGeAlD
Glipizide—Gliclazide—CYP2C19—coronary artery disease	9.07e-05	0.0354	CrCbGaD
Glipizide—Chlorpropamide—CYP2C19—coronary artery disease	7.05e-05	0.0275	CrCbGaD
Glipizide—Tolbutamide—CYP2C19—coronary artery disease	6.87e-05	0.0268	CrCbGaD
Glipizide—Gliclazide—ALB—coronary artery disease	5.03e-05	0.0196	CrCbGaD
Glipizide—Glyburide—CYP2C19—coronary artery disease	4.77e-05	0.0186	CrCbGaD
Glipizide—Hypertension—Timolol—coronary artery disease	4.18e-05	0.000442	CcSEcCtD
Glipizide—Constipation—Furosemide—coronary artery disease	4.18e-05	0.000442	CcSEcCtD
Glipizide—Pain—Furosemide—coronary artery disease	4.18e-05	0.000442	CcSEcCtD
Glipizide—Hypersensitivity—Niacin—coronary artery disease	4.17e-05	0.000442	CcSEcCtD
Glipizide—Ill-defined disorder—Lisinopril—coronary artery disease	4.17e-05	0.000441	CcSEcCtD
Glipizide—Discomfort—Ramipril—coronary artery disease	4.16e-05	0.000441	CcSEcCtD
Glipizide—Asthenia—Olmesartan—coronary artery disease	4.16e-05	0.00044	CcSEcCtD
Glipizide—Headache—Clopidogrel—coronary artery disease	4.16e-05	0.00044	CcSEcCtD
Glipizide—Rash—Lovastatin—coronary artery disease	4.16e-05	0.00044	CcSEcCtD
Glipizide—Dermatitis—Lovastatin—coronary artery disease	4.15e-05	0.00044	CcSEcCtD
Glipizide—Dyspepsia—Losartan—coronary artery disease	4.15e-05	0.000439	CcSEcCtD
Glipizide—Feeling abnormal—Perindopril—coronary artery disease	4.14e-05	0.000438	CcSEcCtD
Glipizide—Headache—Lovastatin—coronary artery disease	4.13e-05	0.000437	CcSEcCtD
Glipizide—Pruritus—Valsartan—coronary artery disease	4.12e-05	0.000436	CcSEcCtD
Glipizide—Arthralgia—Timolol—coronary artery disease	4.12e-05	0.000436	CcSEcCtD
Glipizide—Myalgia—Timolol—coronary artery disease	4.12e-05	0.000436	CcSEcCtD
Glipizide—Vomiting—Ezetimibe—coronary artery disease	4.11e-05	0.000435	CcSEcCtD
Glipizide—Hypersensitivity—Pravastatin—coronary artery disease	4.11e-05	0.000435	CcSEcCtD
Glipizide—Gastrointestinal pain—Perindopril—coronary artery disease	4.11e-05	0.000435	CcSEcCtD
Glipizide—Anxiety—Timolol—coronary artery disease	4.11e-05	0.000435	CcSEcCtD
Glipizide—Pruritus—Olmesartan—coronary artery disease	4.1e-05	0.000434	CcSEcCtD
Glipizide—Decreased appetite—Losartan—coronary artery disease	4.1e-05	0.000434	CcSEcCtD
Glipizide—Abdominal pain—Captopril—coronary artery disease	4.09e-05	0.000433	CcSEcCtD
Glipizide—Dizziness—Simvastatin—coronary artery disease	4.08e-05	0.000432	CcSEcCtD
Glipizide—Rash—Ezetimibe—coronary artery disease	4.08e-05	0.000432	CcSEcCtD
Glipizide—Dermatitis—Ezetimibe—coronary artery disease	4.07e-05	0.000431	CcSEcCtD
Glipizide—Confusional state—Ramipril—coronary artery disease	4.07e-05	0.000431	CcSEcCtD
Glipizide—Discomfort—Timolol—coronary artery disease	4.07e-05	0.000431	CcSEcCtD
Glipizide—Asthenia—Niacin—coronary artery disease	4.06e-05	0.00043	CcSEcCtD
Glipizide—Headache—Ezetimibe—coronary artery disease	4.05e-05	0.000429	CcSEcCtD
Glipizide—Malaise—Lisinopril—coronary artery disease	4.05e-05	0.000429	CcSEcCtD
Glipizide—Oedema—Ramipril—coronary artery disease	4.04e-05	0.000428	CcSEcCtD
Glipizide—Vertigo—Lisinopril—coronary artery disease	4.03e-05	0.000427	CcSEcCtD
Glipizide—Constipation—Losartan—coronary artery disease	4.03e-05	0.000426	CcSEcCtD
Glipizide—Pain—Losartan—coronary artery disease	4.03e-05	0.000426	CcSEcCtD
Glipizide—Syncope—Lisinopril—coronary artery disease	4.03e-05	0.000426	CcSEcCtD
Glipizide—Vomiting—Eplerenone—coronary artery disease	4.03e-05	0.000426	CcSEcCtD
Glipizide—Feeling abnormal—Furosemide—coronary artery disease	4.02e-05	0.000426	CcSEcCtD
Glipizide—Leukopenia—Lisinopril—coronary artery disease	4.02e-05	0.000425	CcSEcCtD
Glipizide—Nausea—Fenofibrate—coronary artery disease	4.01e-05	0.000425	CcSEcCtD
Glipizide—Pruritus—Niacin—coronary artery disease	4.01e-05	0.000424	CcSEcCtD
Glipizide—Asthenia—Pravastatin—coronary artery disease	4e-05	0.000424	CcSEcCtD
Glipizide—Gastrointestinal pain—Furosemide—coronary artery disease	3.99e-05	0.000423	CcSEcCtD
Glipizide—Rash—Eplerenone—coronary artery disease	3.99e-05	0.000423	CcSEcCtD
Glipizide—Urticaria—Perindopril—coronary artery disease	3.99e-05	0.000422	CcSEcCtD
Glipizide—Hypersensitivity—Trandolapril—coronary artery disease	3.99e-05	0.000422	CcSEcCtD
Glipizide—Dermatitis—Eplerenone—coronary artery disease	3.99e-05	0.000422	CcSEcCtD
Glipizide—Diarrhoea—Valsartan—coronary artery disease	3.99e-05	0.000422	CcSEcCtD
Glipizide—Confusional state—Timolol—coronary artery disease	3.98e-05	0.000422	CcSEcCtD
Glipizide—Shock—Ramipril—coronary artery disease	3.97e-05	0.000421	CcSEcCtD
Glipizide—Hypersensitivity—Enalapril—coronary artery disease	3.97e-05	0.000421	CcSEcCtD
Glipizide—Abdominal pain—Perindopril—coronary artery disease	3.97e-05	0.00042	CcSEcCtD
Glipizide—Diarrhoea—Olmesartan—coronary artery disease	3.97e-05	0.00042	CcSEcCtD
Glipizide—Headache—Eplerenone—coronary artery disease	3.97e-05	0.00042	CcSEcCtD
Glipizide—Thrombocytopenia—Ramipril—coronary artery disease	3.96e-05	0.000419	CcSEcCtD
Glipizide—Oedema—Timolol—coronary artery disease	3.95e-05	0.000418	CcSEcCtD
Glipizide—Pruritus—Pravastatin—coronary artery disease	3.95e-05	0.000418	CcSEcCtD
Glipizide—Loss of consciousness—Lisinopril—coronary artery disease	3.95e-05	0.000418	CcSEcCtD
Glipizide—Nausea—Clopidogrel—coronary artery disease	3.94e-05	0.000417	CcSEcCtD
Glipizide—Vomiting—Simvastatin—coronary artery disease	3.92e-05	0.000415	CcSEcCtD
Glipizide—Hypersensitivity—Telmisartan—coronary artery disease	3.92e-05	0.000415	CcSEcCtD
Glipizide—Nausea—Lovastatin—coronary artery disease	3.92e-05	0.000415	CcSEcCtD
Glipizide—Hyperhidrosis—Ramipril—coronary artery disease	3.91e-05	0.000413	CcSEcCtD
Glipizide—Rash—Simvastatin—coronary artery disease	3.89e-05	0.000412	CcSEcCtD
Glipizide—Dermatitis—Simvastatin—coronary artery disease	3.89e-05	0.000411	CcSEcCtD
Glipizide—Asthenia—Trandolapril—coronary artery disease	3.89e-05	0.000411	CcSEcCtD
Glipizide—Shock—Timolol—coronary artery disease	3.89e-05	0.000411	CcSEcCtD
Glipizide—Feeling abnormal—Losartan—coronary artery disease	3.88e-05	0.000411	CcSEcCtD
Glipizide—Urticaria—Furosemide—coronary artery disease	3.88e-05	0.000411	CcSEcCtD
Glipizide—Diarrhoea—Niacin—coronary artery disease	3.88e-05	0.00041	CcSEcCtD
Glipizide—Asthenia—Enalapril—coronary artery disease	3.87e-05	0.00041	CcSEcCtD
Glipizide—Headache—Simvastatin—coronary artery disease	3.86e-05	0.000409	CcSEcCtD
Glipizide—Abdominal pain—Furosemide—coronary artery disease	3.86e-05	0.000409	CcSEcCtD
Glipizide—Gastrointestinal pain—Losartan—coronary artery disease	3.85e-05	0.000408	CcSEcCtD
Glipizide—Dizziness—Valsartan—coronary artery disease	3.85e-05	0.000408	CcSEcCtD
Glipizide—Anorexia—Ramipril—coronary artery disease	3.85e-05	0.000408	CcSEcCtD
Glipizide—Nausea—Ezetimibe—coronary artery disease	3.84e-05	0.000407	CcSEcCtD
Glipizide—Dizziness—Olmesartan—coronary artery disease	3.83e-05	0.000406	CcSEcCtD
Glipizide—Pruritus—Trandolapril—coronary artery disease	3.83e-05	0.000406	CcSEcCtD
Glipizide—Arthralgia—Lisinopril—coronary artery disease	3.82e-05	0.000405	CcSEcCtD
Glipizide—Myalgia—Lisinopril—coronary artery disease	3.82e-05	0.000405	CcSEcCtD
Glipizide—Hyperhidrosis—Timolol—coronary artery disease	3.82e-05	0.000404	CcSEcCtD
Glipizide—Asthenia—Telmisartan—coronary artery disease	3.82e-05	0.000404	CcSEcCtD
Glipizide—Pruritus—Enalapril—coronary artery disease	3.82e-05	0.000404	CcSEcCtD
Glipizide—Diarrhoea—Pravastatin—coronary artery disease	3.82e-05	0.000404	CcSEcCtD
Glipizide—Anxiety—Lisinopril—coronary artery disease	3.81e-05	0.000403	CcSEcCtD
Glipizide—Discomfort—Lisinopril—coronary artery disease	3.78e-05	0.0004	CcSEcCtD
Glipizide—Anorexia—Timolol—coronary artery disease	3.76e-05	0.000398	CcSEcCtD
Glipizide—Pruritus—Telmisartan—coronary artery disease	3.76e-05	0.000398	CcSEcCtD
Glipizide—Nausea—Eplerenone—coronary artery disease	3.76e-05	0.000398	CcSEcCtD
Glipizide—Dizziness—Niacin—coronary artery disease	3.75e-05	0.000396	CcSEcCtD
Glipizide—Urticaria—Losartan—coronary artery disease	3.74e-05	0.000396	CcSEcCtD
Glipizide—Abdominal pain—Losartan—coronary artery disease	3.72e-05	0.000394	CcSEcCtD
Glipizide—Asthenia—Captopril—coronary artery disease	3.71e-05	0.000393	CcSEcCtD
Glipizide—Diarrhoea—Trandolapril—coronary artery disease	3.71e-05	0.000392	CcSEcCtD
Glipizide—Vomiting—Valsartan—coronary artery disease	3.7e-05	0.000392	CcSEcCtD
Glipizide—Confusional state—Lisinopril—coronary artery disease	3.69e-05	0.000391	CcSEcCtD
Glipizide—Diarrhoea—Enalapril—coronary artery disease	3.69e-05	0.000391	CcSEcCtD
Glipizide—Dizziness—Pravastatin—coronary artery disease	3.69e-05	0.00039	CcSEcCtD
Glipizide—Vomiting—Olmesartan—coronary artery disease	3.69e-05	0.00039	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.68e-05	0.00039	CcSEcCtD
Glipizide—Rash—Valsartan—coronary artery disease	3.67e-05	0.000389	CcSEcCtD
Glipizide—Dermatitis—Valsartan—coronary artery disease	3.67e-05	0.000388	CcSEcCtD
Glipizide—Nausea—Simvastatin—coronary artery disease	3.66e-05	0.000388	CcSEcCtD
Glipizide—Oedema—Lisinopril—coronary artery disease	3.66e-05	0.000388	CcSEcCtD
Glipizide—Pruritus—Captopril—coronary artery disease	3.66e-05	0.000387	CcSEcCtD
Glipizide—Rash—Olmesartan—coronary artery disease	3.66e-05	0.000387	CcSEcCtD
Glipizide—Insomnia—Ramipril—coronary artery disease	3.65e-05	0.000387	CcSEcCtD
Glipizide—Dermatitis—Olmesartan—coronary artery disease	3.65e-05	0.000387	CcSEcCtD
Glipizide—Headache—Valsartan—coronary artery disease	3.65e-05	0.000386	CcSEcCtD
Glipizide—Diarrhoea—Telmisartan—coronary artery disease	3.64e-05	0.000385	CcSEcCtD
Glipizide—Headache—Olmesartan—coronary artery disease	3.63e-05	0.000384	CcSEcCtD
Glipizide—Paraesthesia—Ramipril—coronary artery disease	3.63e-05	0.000384	CcSEcCtD
Glipizide—Shock—Lisinopril—coronary artery disease	3.6e-05	0.000382	CcSEcCtD
Glipizide—Asthenia—Perindopril—coronary artery disease	3.6e-05	0.000381	CcSEcCtD
Glipizide—Dyspnoea—Ramipril—coronary artery disease	3.6e-05	0.000381	CcSEcCtD
Glipizide—Vomiting—Niacin—coronary artery disease	3.6e-05	0.000381	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Timolol—coronary artery disease	3.6e-05	0.000381	CcSEcCtD
Glipizide—Hypersensitivity—Furosemide—coronary artery disease	3.6e-05	0.000381	CcSEcCtD
Glipizide—Somnolence—Ramipril—coronary artery disease	3.59e-05	0.00038	CcSEcCtD
Glipizide—Thrombocytopenia—Lisinopril—coronary artery disease	3.59e-05	0.00038	CcSEcCtD
Glipizide—Dizziness—Trandolapril—coronary artery disease	3.58e-05	0.000379	CcSEcCtD
Glipizide—Insomnia—Timolol—coronary artery disease	3.57e-05	0.000378	CcSEcCtD
Glipizide—Rash—Niacin—coronary artery disease	3.57e-05	0.000378	CcSEcCtD
Glipizide—Dermatitis—Niacin—coronary artery disease	3.57e-05	0.000378	CcSEcCtD
Glipizide—Dizziness—Enalapril—coronary artery disease	3.57e-05	0.000378	CcSEcCtD
Glipizide—Dyspepsia—Ramipril—coronary artery disease	3.56e-05	0.000376	CcSEcCtD
Glipizide—Pruritus—Perindopril—coronary artery disease	3.55e-05	0.000376	CcSEcCtD
Glipizide—Headache—Niacin—coronary artery disease	3.55e-05	0.000376	CcSEcCtD
Glipizide—Paraesthesia—Timolol—coronary artery disease	3.55e-05	0.000375	CcSEcCtD
Glipizide—Vomiting—Pravastatin—coronary artery disease	3.55e-05	0.000375	CcSEcCtD
Glipizide—Hyperhidrosis—Lisinopril—coronary artery disease	3.54e-05	0.000375	CcSEcCtD
Glipizide—Diarrhoea—Captopril—coronary artery disease	3.54e-05	0.000375	CcSEcCtD
Glipizide—Dyspnoea—Timolol—coronary artery disease	3.52e-05	0.000373	CcSEcCtD
Glipizide—Dizziness—Telmisartan—coronary artery disease	3.52e-05	0.000372	CcSEcCtD
Glipizide—Rash—Pravastatin—coronary artery disease	3.52e-05	0.000372	CcSEcCtD
Glipizide—Dermatitis—Pravastatin—coronary artery disease	3.51e-05	0.000372	CcSEcCtD
Glipizide—Decreased appetite—Ramipril—coronary artery disease	3.51e-05	0.000372	CcSEcCtD
Glipizide—Somnolence—Timolol—coronary artery disease	3.51e-05	0.000372	CcSEcCtD
Glipizide—Asthenia—Furosemide—coronary artery disease	3.5e-05	0.000371	CcSEcCtD
Glipizide—Headache—Pravastatin—coronary artery disease	3.49e-05	0.00037	CcSEcCtD
Glipizide—Anorexia—Lisinopril—coronary artery disease	3.49e-05	0.00037	CcSEcCtD
Glipizide—Gastrointestinal disorder—Ramipril—coronary artery disease	3.49e-05	0.000369	CcSEcCtD
Glipizide—Dyspepsia—Timolol—coronary artery disease	3.48e-05	0.000368	CcSEcCtD
Glipizide—Hypersensitivity—Losartan—coronary artery disease	3.47e-05	0.000367	CcSEcCtD
Glipizide—Nausea—Valsartan—coronary artery disease	3.46e-05	0.000366	CcSEcCtD
Glipizide—Pruritus—Furosemide—coronary artery disease	3.45e-05	0.000366	CcSEcCtD
Glipizide—Constipation—Ramipril—coronary artery disease	3.45e-05	0.000366	CcSEcCtD
Glipizide—Nausea—Olmesartan—coronary artery disease	3.44e-05	0.000365	CcSEcCtD
Glipizide—Vomiting—Trandolapril—coronary artery disease	3.44e-05	0.000364	CcSEcCtD
Glipizide—Diarrhoea—Perindopril—coronary artery disease	3.44e-05	0.000364	CcSEcCtD
Glipizide—Decreased appetite—Timolol—coronary artery disease	3.43e-05	0.000363	CcSEcCtD
Glipizide—Vomiting—Enalapril—coronary artery disease	3.43e-05	0.000363	CcSEcCtD
Glipizide—Dizziness—Captopril—coronary artery disease	3.42e-05	0.000362	CcSEcCtD
Glipizide—Rash—Trandolapril—coronary artery disease	3.41e-05	0.000361	CcSEcCtD
Glipizide—Dermatitis—Trandolapril—coronary artery disease	3.41e-05	0.000361	CcSEcCtD
Glipizide—Gastrointestinal disorder—Timolol—coronary artery disease	3.41e-05	0.000361	CcSEcCtD
Glipizide—Rash—Enalapril—coronary artery disease	3.4e-05	0.00036	CcSEcCtD
Glipizide—Dermatitis—Enalapril—coronary artery disease	3.4e-05	0.00036	CcSEcCtD
Glipizide—Headache—Trandolapril—coronary artery disease	3.39e-05	0.000359	CcSEcCtD
Glipizide—Vomiting—Telmisartan—coronary artery disease	3.38e-05	0.000358	CcSEcCtD
Glipizide—Asthenia—Losartan—coronary artery disease	3.38e-05	0.000358	CcSEcCtD
Glipizide—Headache—Enalapril—coronary artery disease	3.38e-05	0.000358	CcSEcCtD
Glipizide—Pain—Timolol—coronary artery disease	3.38e-05	0.000357	CcSEcCtD
Glipizide—Nausea—Niacin—coronary artery disease	3.36e-05	0.000356	CcSEcCtD
Glipizide—Rash—Telmisartan—coronary artery disease	3.35e-05	0.000355	CcSEcCtD
Glipizide—Dermatitis—Telmisartan—coronary artery disease	3.35e-05	0.000355	CcSEcCtD
Glipizide—Diarrhoea—Furosemide—coronary artery disease	3.34e-05	0.000354	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.34e-05	0.000353	CcSEcCtD
Glipizide—Pruritus—Losartan—coronary artery disease	3.33e-05	0.000353	CcSEcCtD
Glipizide—Headache—Telmisartan—coronary artery disease	3.33e-05	0.000353	CcSEcCtD
Glipizide—Feeling abnormal—Ramipril—coronary artery disease	3.33e-05	0.000352	CcSEcCtD
Glipizide—Dizziness—Perindopril—coronary artery disease	3.32e-05	0.000352	CcSEcCtD
Glipizide—Insomnia—Lisinopril—coronary artery disease	3.31e-05	0.000351	CcSEcCtD
Glipizide—Nausea—Pravastatin—coronary artery disease	3.31e-05	0.000351	CcSEcCtD
Glipizide—Gastrointestinal pain—Ramipril—coronary artery disease	3.3e-05	0.00035	CcSEcCtD
Glipizide—Paraesthesia—Lisinopril—coronary artery disease	3.29e-05	0.000348	CcSEcCtD
Glipizide—Vomiting—Captopril—coronary artery disease	3.29e-05	0.000348	CcSEcCtD
Glipizide—Dyspnoea—Lisinopril—coronary artery disease	3.27e-05	0.000346	CcSEcCtD
Glipizide—Rash—Captopril—coronary artery disease	3.26e-05	0.000345	CcSEcCtD
Glipizide—Dermatitis—Captopril—coronary artery disease	3.26e-05	0.000345	CcSEcCtD
Glipizide—Somnolence—Lisinopril—coronary artery disease	3.26e-05	0.000345	CcSEcCtD
Glipizide—Feeling abnormal—Timolol—coronary artery disease	3.25e-05	0.000345	CcSEcCtD
Glipizide—Headache—Captopril—coronary artery disease	3.24e-05	0.000343	CcSEcCtD
Glipizide—Gastrointestinal pain—Timolol—coronary artery disease	3.23e-05	0.000342	CcSEcCtD
Glipizide—Dizziness—Furosemide—coronary artery disease	3.23e-05	0.000342	CcSEcCtD
Glipizide—Dyspepsia—Lisinopril—coronary artery disease	3.23e-05	0.000341	CcSEcCtD
Glipizide—Diarrhoea—Losartan—coronary artery disease	3.22e-05	0.000341	CcSEcCtD
Glipizide—Nausea—Trandolapril—coronary artery disease	3.22e-05	0.000341	CcSEcCtD
Glipizide—Urticaria—Ramipril—coronary artery disease	3.21e-05	0.00034	CcSEcCtD
Glipizide—Nausea—Enalapril—coronary artery disease	3.2e-05	0.000339	CcSEcCtD
Glipizide—Vomiting—Perindopril—coronary artery disease	3.19e-05	0.000338	CcSEcCtD
Glipizide—Abdominal pain—Ramipril—coronary artery disease	3.19e-05	0.000338	CcSEcCtD
Glipizide—Decreased appetite—Lisinopril—coronary artery disease	3.18e-05	0.000337	CcSEcCtD
Glipizide—Rash—Perindopril—coronary artery disease	3.17e-05	0.000335	CcSEcCtD
Glipizide—Dermatitis—Perindopril—coronary artery disease	3.16e-05	0.000335	CcSEcCtD
Glipizide—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.16e-05	0.000335	CcSEcCtD
Glipizide—Nausea—Telmisartan—coronary artery disease	3.16e-05	0.000335	CcSEcCtD
Glipizide—Headache—Perindopril—coronary artery disease	3.15e-05	0.000333	CcSEcCtD
Glipizide—Urticaria—Timolol—coronary artery disease	3.14e-05	0.000332	CcSEcCtD
Glipizide—Pain—Lisinopril—coronary artery disease	3.13e-05	0.000332	CcSEcCtD
Glipizide—Constipation—Lisinopril—coronary artery disease	3.13e-05	0.000332	CcSEcCtD
Glipizide—Abdominal pain—Timolol—coronary artery disease	3.12e-05	0.00033	CcSEcCtD
Glipizide—Dizziness—Losartan—coronary artery disease	3.12e-05	0.00033	CcSEcCtD
Glipizide—Vomiting—Furosemide—coronary artery disease	3.1e-05	0.000329	CcSEcCtD
Glipizide—Rash—Furosemide—coronary artery disease	3.08e-05	0.000326	CcSEcCtD
Glipizide—Dermatitis—Furosemide—coronary artery disease	3.08e-05	0.000326	CcSEcCtD
Glipizide—Nausea—Captopril—coronary artery disease	3.07e-05	0.000325	CcSEcCtD
Glipizide—Headache—Furosemide—coronary artery disease	3.06e-05	0.000324	CcSEcCtD
Glipizide—Feeling abnormal—Lisinopril—coronary artery disease	3.02e-05	0.00032	CcSEcCtD
Glipizide—Gastrointestinal pain—Lisinopril—coronary artery disease	3e-05	0.000317	CcSEcCtD
Glipizide—Vomiting—Losartan—coronary artery disease	3e-05	0.000317	CcSEcCtD
Glipizide—Nausea—Perindopril—coronary artery disease	2.98e-05	0.000316	CcSEcCtD
Glipizide—Hypersensitivity—Ramipril—coronary artery disease	2.98e-05	0.000315	CcSEcCtD
Glipizide—Rash—Losartan—coronary artery disease	2.97e-05	0.000314	CcSEcCtD
Glipizide—Dermatitis—Losartan—coronary artery disease	2.97e-05	0.000314	CcSEcCtD
Glipizide—Headache—Losartan—coronary artery disease	2.95e-05	0.000312	CcSEcCtD
Glipizide—Urticaria—Lisinopril—coronary artery disease	2.91e-05	0.000308	CcSEcCtD
Glipizide—Hypersensitivity—Timolol—coronary artery disease	2.91e-05	0.000308	CcSEcCtD
Glipizide—Nausea—Furosemide—coronary artery disease	2.9e-05	0.000307	CcSEcCtD
Glipizide—Asthenia—Ramipril—coronary artery disease	2.9e-05	0.000307	CcSEcCtD
Glipizide—Abdominal pain—Lisinopril—coronary artery disease	2.9e-05	0.000307	CcSEcCtD
Glipizide—Pruritus—Ramipril—coronary artery disease	2.86e-05	0.000303	CcSEcCtD
Glipizide—Asthenia—Timolol—coronary artery disease	2.83e-05	0.0003	CcSEcCtD
Glipizide—Nausea—Losartan—coronary artery disease	2.8e-05	0.000296	CcSEcCtD
Glipizide—Pruritus—Timolol—coronary artery disease	2.79e-05	0.000296	CcSEcCtD
Glipizide—Diarrhoea—Ramipril—coronary artery disease	2.76e-05	0.000293	CcSEcCtD
Glipizide—Diarrhoea—Timolol—coronary artery disease	2.7e-05	0.000286	CcSEcCtD
Glipizide—Hypersensitivity—Lisinopril—coronary artery disease	2.7e-05	0.000286	CcSEcCtD
Glipizide—Dizziness—Ramipril—coronary artery disease	2.67e-05	0.000283	CcSEcCtD
Glipizide—Glyburide—ALB—coronary artery disease	2.64e-05	0.0103	CrCbGaD
Glipizide—Asthenia—Lisinopril—coronary artery disease	2.63e-05	0.000278	CcSEcCtD
Glipizide—Dizziness—Timolol—coronary artery disease	2.61e-05	0.000276	CcSEcCtD
Glipizide—Pruritus—Lisinopril—coronary artery disease	2.59e-05	0.000274	CcSEcCtD
Glipizide—Vomiting—Ramipril—coronary artery disease	2.57e-05	0.000272	CcSEcCtD
Glipizide—Rash—Ramipril—coronary artery disease	2.55e-05	0.00027	CcSEcCtD
Glipizide—Dermatitis—Ramipril—coronary artery disease	2.54e-05	0.000269	CcSEcCtD
Glipizide—Headache—Ramipril—coronary artery disease	2.53e-05	0.000268	CcSEcCtD
Glipizide—Vomiting—Timolol—coronary artery disease	2.51e-05	0.000266	CcSEcCtD
Glipizide—Diarrhoea—Lisinopril—coronary artery disease	2.51e-05	0.000265	CcSEcCtD
Glipizide—Rash—Timolol—coronary artery disease	2.49e-05	0.000264	CcSEcCtD
Glipizide—Dermatitis—Timolol—coronary artery disease	2.49e-05	0.000263	CcSEcCtD
Glipizide—Headache—Timolol—coronary artery disease	2.47e-05	0.000262	CcSEcCtD
Glipizide—Dizziness—Lisinopril—coronary artery disease	2.42e-05	0.000256	CcSEcCtD
Glipizide—Nausea—Ramipril—coronary artery disease	2.4e-05	0.000254	CcSEcCtD
Glipizide—Nausea—Timolol—coronary artery disease	2.35e-05	0.000248	CcSEcCtD
Glipizide—Vomiting—Lisinopril—coronary artery disease	2.33e-05	0.000247	CcSEcCtD
Glipizide—Rash—Lisinopril—coronary artery disease	2.31e-05	0.000245	CcSEcCtD
Glipizide—Dermatitis—Lisinopril—coronary artery disease	2.31e-05	0.000244	CcSEcCtD
Glipizide—Headache—Lisinopril—coronary artery disease	2.3e-05	0.000243	CcSEcCtD
Glipizide—Nausea—Lisinopril—coronary artery disease	2.18e-05	0.00023	CcSEcCtD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	6.05e-06	0.000133	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PRKCD—coronary artery disease	6.01e-06	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	6e-06	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PYGB—coronary artery disease	5.98e-06	0.000131	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CKB—coronary artery disease	5.98e-06	0.000131	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—coronary artery disease	5.94e-06	0.00013	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AGT—coronary artery disease	5.87e-06	0.000129	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOA1—coronary artery disease	5.87e-06	0.000129	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—coronary artery disease	5.77e-06	0.000127	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—coronary artery disease	5.76e-06	0.000126	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOA1—coronary artery disease	5.69e-06	0.000125	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—coronary artery disease	5.63e-06	0.000124	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLIN1—coronary artery disease	5.62e-06	0.000124	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PFKFB3—coronary artery disease	5.62e-06	0.000124	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—COX5B—coronary artery disease	5.62e-06	0.000124	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DLAT—coronary artery disease	5.62e-06	0.000124	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM2—coronary artery disease	5.62e-06	0.000124	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	5.6e-06	0.000123	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CKM—coronary artery disease	5.6e-06	0.000123	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPAP2B—coronary artery disease	5.6e-06	0.000123	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARGC1A—coronary artery disease	5.57e-06	0.000122	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—coronary artery disease	5.55e-06	0.000122	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAT—coronary artery disease	5.47e-06	0.00012	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	5.35e-06	0.000117	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SULT1E1—coronary artery disease	5.33e-06	0.000117	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK14—coronary artery disease	5.32e-06	0.000117	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOB—coronary artery disease	5.31e-06	0.000117	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—coronary artery disease	5.3e-06	0.000116	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—coronary artery disease	5.22e-06	0.000115	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PDK4—coronary artery disease	5.21e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PYGM—coronary artery disease	5.21e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SULT4A1—coronary artery disease	5.21e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CKMT2—coronary artery disease	5.21e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	5.21e-06	0.000114	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK1—coronary artery disease	5.2e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—POMC—coronary artery disease	5.19e-06	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	5.18e-06	0.000114	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—coronary artery disease	5.17e-06	0.000114	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—coronary artery disease	5.17e-06	0.000114	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—POMC—coronary artery disease	5.1e-06	0.000112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HK2—coronary artery disease	5.09e-06	0.000112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKR1B1—coronary artery disease	5.09e-06	0.000112	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LPL—coronary artery disease	5.07e-06	0.000111	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—coronary artery disease	5.01e-06	0.00011	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPX1—coronary artery disease	4.95e-06	0.000109	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—coronary artery disease	4.95e-06	0.000109	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—POMC—coronary artery disease	4.94e-06	0.000109	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC27A1—coronary artery disease	4.88e-06	0.000107	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CD36—coronary artery disease	4.82e-06	0.000106	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LCAT—coronary artery disease	4.78e-06	0.000105	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CPT1B—coronary artery disease	4.78e-06	0.000105	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPP2CA—coronary artery disease	4.76e-06	0.000105	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA4—coronary artery disease	4.69e-06	0.000103	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—coronary artery disease	4.65e-06	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMGCS2—coronary artery disease	4.64e-06	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PFKM—coronary artery disease	4.64e-06	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GYG1—coronary artery disease	4.64e-06	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LDHA—coronary artery disease	4.64e-06	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GK—coronary artery disease	4.64e-06	0.000102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GATM—coronary artery disease	4.64e-06	0.000102	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	4.61e-06	0.000101	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—coronary artery disease	4.57e-06	0.0001	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCLM—coronary artery disease	4.53e-06	9.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PDHA1—coronary artery disease	4.53e-06	9.96e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—coronary artery disease	4.51e-06	9.9e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—coronary artery disease	4.45e-06	9.76e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCH1—coronary artery disease	4.43e-06	9.72e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AK1—coronary artery disease	4.43e-06	9.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	4.39e-06	9.65e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TXNRD1—coronary artery disease	4.39e-06	9.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP11B2—coronary artery disease	4.39e-06	9.64e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AGT—coronary artery disease	4.34e-06	9.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC22A3—coronary artery disease	4.32e-06	9.5e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—coronary artery disease	4.31e-06	9.47e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—coronary artery disease	4.29e-06	9.43e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HADH—coronary artery disease	4.26e-06	9.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ARNTL—coronary artery disease	4.26e-06	9.36e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—coronary artery disease	4.25e-06	9.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MDH2—coronary artery disease	4.24e-06	9.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UGCG—coronary artery disease	4.24e-06	9.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCD1—coronary artery disease	4.24e-06	9.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPAT—coronary artery disease	4.24e-06	9.32e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA1—coronary artery disease	4.2e-06	9.23e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	4.2e-06	9.21e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	4.09e-06	8.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PGM1—coronary artery disease	4.08e-06	8.97e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—coronary artery disease	4.07e-06	8.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX2—coronary artery disease	4.04e-06	8.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA2—coronary artery disease	4.04e-06	8.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	4.04e-06	8.87e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.03e-06	8.84e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—coronary artery disease	3.99e-06	8.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG5—coronary artery disease	3.99e-06	8.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HK1—coronary artery disease	3.99e-06	8.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SULT1A1—coronary artery disease	3.99e-06	8.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX4—coronary artery disease	3.99e-06	8.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	3.99e-06	8.76e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CKB—coronary artery disease	3.95e-06	8.66e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PYGB—coronary artery disease	3.95e-06	8.66e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HADHA—coronary artery disease	3.94e-06	8.66e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—coronary artery disease	3.94e-06	8.66e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA1—coronary artery disease	3.9e-06	8.56e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPA—coronary artery disease	3.85e-06	8.47e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLCB3—coronary artery disease	3.73e-06	8.2e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DLAT—coronary artery disease	3.71e-06	8.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM2—coronary artery disease	3.71e-06	8.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLIN1—coronary artery disease	3.71e-06	8.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PFKFB3—coronary artery disease	3.71e-06	8.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COX5B—coronary artery disease	3.71e-06	8.15e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA5—coronary artery disease	3.7e-06	8.12e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—coronary artery disease	3.68e-06	8.09e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—POMC—coronary artery disease	3.65e-06	8.02e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—P4HB—coronary artery disease	3.62e-06	7.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.59e-06	7.88e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	3.56e-06	7.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.52e-06	7.72e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.52e-06	7.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.48e-06	7.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.35e-06	7.37e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HK2—coronary artery disease	3.35e-06	7.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—VCAN—coronary artery disease	3.35e-06	7.36e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—coronary artery disease	3.33e-06	7.32e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDOA—coronary artery disease	3.33e-06	7.31e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DCN—coronary artery disease	3.23e-06	7.09e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.22e-06	7.06e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—coronary artery disease	3.19e-06	7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LCAT—coronary artery disease	3.15e-06	6.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.15e-06	6.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH2—coronary artery disease	3.14e-06	6.9e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA4—coronary artery disease	3.1e-06	6.8e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.06e-06	6.73e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HBA1—coronary artery disease	3.06e-06	6.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2C19—coronary artery disease	3.06e-06	6.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	3.06e-06	6.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LIPC—coronary artery disease	3.06e-06	6.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOC3—coronary artery disease	3.04e-06	6.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LDLR—coronary artery disease	3.02e-06	6.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.02e-06	6.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.99e-06	6.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCLM—coronary artery disease	2.99e-06	6.57e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—coronary artery disease	2.99e-06	6.56e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC9A1—coronary artery disease	2.99e-06	6.56e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCLC—coronary artery disease	2.95e-06	6.49e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CETP—coronary artery disease	2.95e-06	6.49e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SDC1—coronary artery disease	2.92e-06	6.42e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—coronary artery disease	2.91e-06	6.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.9e-06	6.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.9e-06	6.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.85e-06	6.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HADH—coronary artery disease	2.81e-06	6.17e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.81e-06	6.17e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.76e-06	6.06e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.76e-06	6.06e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.75e-06	6.05e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CTGF—coronary artery disease	2.7e-06	5.92e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT2—coronary artery disease	2.67e-06	5.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.67e-06	5.87e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX2—coronary artery disease	2.66e-06	5.85e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.66e-06	5.85e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA2—coronary artery disease	2.66e-06	5.85e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX4—coronary artery disease	2.63e-06	5.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HK1—coronary artery disease	2.63e-06	5.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.63e-06	5.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.63e-06	5.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HADHA—coronary artery disease	2.6e-06	5.71e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.57e-06	5.65e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPA—coronary artery disease	2.54e-06	5.58e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—coronary artery disease	2.5e-06	5.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.46e-06	5.41e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.46e-06	5.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA5—coronary artery disease	2.44e-06	5.35e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—coronary artery disease	2.43e-06	5.33e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.41e-06	5.29e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—P4HB—coronary artery disease	2.39e-06	5.25e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.38e-06	5.23e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.35e-06	5.15e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GGT1—coronary artery disease	2.31e-06	5.07e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT1—coronary artery disease	2.31e-06	5.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—VCAN—coronary artery disease	2.21e-06	4.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.19e-06	4.82e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DCN—coronary artery disease	2.13e-06	4.68e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.07e-06	4.55e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.07e-06	4.55e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.05e-06	4.51e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—coronary artery disease	2.04e-06	4.49e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.04e-06	4.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HBA1—coronary artery disease	2.02e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LIPC—coronary artery disease	2.02e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.02e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.02e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAT—coronary artery disease	2.02e-06	4.43e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOC3—coronary artery disease	2.01e-06	4.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LDLR—coronary artery disease	1.99e-06	4.38e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—coronary artery disease	1.98e-06	4.35e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.97e-06	4.33e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.97e-06	4.33e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOB—coronary artery disease	1.96e-06	4.3e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCLC—coronary artery disease	1.95e-06	4.28e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CETP—coronary artery disease	1.95e-06	4.28e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SDC1—coronary artery disease	1.93e-06	4.23e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.9e-06	4.18e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—coronary artery disease	1.88e-06	4.14e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPL—coronary artery disease	1.87e-06	4.1e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—coronary artery disease	1.82e-06	4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.82e-06	4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.82e-06	4e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—coronary artery disease	1.79e-06	3.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CTGF—coronary artery disease	1.78e-06	3.9e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD36—coronary artery disease	1.78e-06	3.9e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT2—coronary artery disease	1.76e-06	3.87e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.76e-06	3.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.75e-06	3.85e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.68e-06	3.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.62e-06	3.56e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AGT—coronary artery disease	1.6e-06	3.51e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.57e-06	3.45e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—coronary artery disease	1.57e-06	3.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA1—coronary artery disease	1.55e-06	3.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GGT1—coronary artery disease	1.52e-06	3.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT1—coronary artery disease	1.52e-06	3.34e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.48e-06	3.26e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—coronary artery disease	1.46e-06	3.22e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.37e-06	3e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—coronary artery disease	1.36e-06	3e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.35e-06	2.97e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.35e-06	2.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—POMC—coronary artery disease	1.35e-06	2.96e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAT—coronary artery disease	1.33e-06	2.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOB—coronary artery disease	1.29e-06	2.83e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.26e-06	2.76e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPL—coronary artery disease	1.23e-06	2.71e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—coronary artery disease	1.23e-06	2.69e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—coronary artery disease	1.2e-06	2.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—coronary artery disease	1.17e-06	2.58e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD36—coronary artery disease	1.17e-06	2.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.16e-06	2.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.11e-06	2.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.07e-06	2.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AGT—coronary artery disease	1.05e-06	2.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—coronary artery disease	1.03e-06	2.27e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA1—coronary artery disease	1.02e-06	2.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—coronary artery disease	9e-07	1.98e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—POMC—coronary artery disease	8.87e-07	1.95e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—coronary artery disease	8.09e-07	1.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—coronary artery disease	7.74e-07	1.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.08e-07	1.55e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	6.6e-07	1.45e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—coronary artery disease	5.39e-07	1.18e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.36e-07	9.56e-06	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—coronary artery disease	3.56e-07	7.81e-06	CbGpPWpGaD
